Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-14

FDA Approved: FLUOROURACIL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for fluorouracil submitted by BluePoint Laboratories, indicating approval of an ANDA supplement. This confirms changes t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)

Snippet

SUPPL AP for FLUOROURACIL (FLUOROURACIL)